The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Pharmacology · Receptor biology

GIP receptor agonism and the argument about direction

AC
a.cardosoTL27 Jun 2025#1

GIP receptor agonism and the argument about direction — setting out what I have, and where I think it stops being reliable.

A question about GIP receptor agonism that I think has a definite answer, unlike most of what I ask here.

I have the reasoning below and I am fairly confident about the direction. I am not confident about the size, and the size is what the decision turns on.

40 likes 14mo
QZ
q.zhao_qaTL3Quality assurance10 Aug 2025 · edited#2

The opening post answers the question as asked. The question underneath it is different.

GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium (contractility). Different tissues respond to the same signal in different ways.

9 likes 12mo
ES
e.steinerTL225 Sep 2025#3
q.zhao_qa, post #2: The opening post answers the question as asked. The question underneath it is different. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium (contractility). Different tissues respond to the same signal in different ways. Go to post

Clear enough that I do not think I have a follow-up, which is unusual.

2 likes in reply to #2 10mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Vagal afferents and the gut-brain pathway — one year on
Vagal afferents and the gut-brain pathway — one year on Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about Vagal afferents rather than a disguised…
AKTLAW 2 136 11mo
GIP receptor agonism and the argument about direction — does this still hold?
GIP receptor agonism and the argument about direction — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A question about GIP receptor agonism…
HMBNSCPWEL+10 14 15k 16h
About the Receptor biology category
GLP-1, GIP, glucagon and amylin receptor signalling, bias, desensitisation and central versus peripheral action. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
OBDOSOIKP+6 10 34k 20d
Receptor desensitisation as a tolerance hypothesis, and its weak evidence
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on receptor…
MAVSOVSKMP+52 57 25k just now
Biased agonism: a real phenomenon, an over-used explanation
Posting this under the heading it deserves: Biased agonism: a real phenomenon, an over-used explanation Everything below is what sits behind that. Trying to work out what would count as evidence on biased…
HASLFRGTSL+130 135 23k 16mo

Related topics — sharing the tags tirzepatide, long read, amylin analogues

TopicParticipantsRepliesViewsActivity
Coming back to: What the published dose-response for semaglutide actually looks like above 2.4 mg
The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody repeats it. I would like to know what…
SCHJSATKO+23 27 9.9k 1mo
Why semaglutide's albumin binding is the whole reason weekly dosing works
Asking directly, because I could not find a straight answer: Why semaglutide's albumin binding is the whole reason weekly dosing works Putting the numbers in the first post, because a question about a…
MMLIYR 2 63k 5mo
Second pass at: Retatrutide dose escalation in the published trials
Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on Retatrutide…
BRNKISTM+115 125 30k 2y
Receptor desensitisation as a tolerance hypothesis, and its weak evidence
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on receptor…
MAVSOVSKMP+52 57 25k just now
Reading SURMOUNT-1 without the press release
Posting this under the heading it deserves: Reading SURMOUNT-1 without the press release Everything below is what sits behind that. What changes if the standard account of reading SURMOUNT-1 without the press…
AVCLAILEAP+103 121 7k 7mo